Identification of new p53 acetylation sites in COS-1 cells

Molecular and Cellular Proteomics

Volumn 8, Issue 6, 2009, Pages 1167-1173

  Joubel, Anita ^a   Chalkley, Robert J ^a   Medzihradszky, Katalin F ^a   Hondermarck, Hubert ^b   Burlingame, Alma L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; PROTEIN P53; SERINE;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, LIQUID; COS CELLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; TANDEM MASS SPECTROMETRY; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 67650564609     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800487-MCP200     Document Type: Article

References (40)

1. Aylon, Y., and Oren, M. (2007) Living with p53, dying of p53. Cell 130, 597-600
2. Van Dyke, T. (2005) Cancer biology: sense out of missense. Nature 434, 287-288 (Pubitemid 40469154)
3. Xu, Y. (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ. 10, 400-403 (Pubitemid 36626351)
4. Appella, E., and Anderson, C. W. (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268, 2764-2772
5. Jabbur, J. R., Tabor, A. D., Cheng, X., Wang, H., Uesugi, M., Lozano, G., and Zhang, W. (2002) Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 8 and Asp21. Oncogene 21, 7100-7113 (Pubitemid 35252984)
6. Gu, W., and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (Pubitemid 27357952)
7. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841 (Pubitemid 28440142)
8. Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839 (Pubitemid 44960094)
9. Wang, Y. H., Tsay, Y. G., Tan, B. C., Lo, W. Y., and Lee, S. C. (2003) Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J. Biol. Chem. 278, 25568-25576
10. Ivanov, G. S., Ivanova, T., Kurash, J., Ivanov, A., Chuikov, S., Gizatullin, F., Herrera-Medina, E. M., Rauscher, F., III, Reinberg, D., and Barlev, N. A. (2007) Methylation-acetylation interplay activates p53 in response to DNA damage. Mol. Cell. Biol. 27, 6756-6769
11. Li, A. G., Piluso, L. G., Cai, X., Gadd, B. J., Ladurner, A. G., and Liu, X. (2007) An acetylation switch in p53 mediates holo-TFIID recruitment. Mol. Cell 28, 408-421 (Pubitemid 350030559)
12. Kurash, J. K., Lei, H., Shen, Q., Marston, W. L., Granda, B. W., Fan, H., Wall, D., Li, E., and Gaudet, F. (2008) Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol. Cell 29, 392-400 (Pubitemid 351215939)
13. Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., and Berger, S. L. (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8, 1243-1254
14. Tang, Y., Zhao, W., Chen, Y., Zhao, Y., and Gu, W. (2008) Acetylation is indispensable for p53 activation. Cell 133, 612-626
15. Lane, D. P., and Crawford, L. V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261-263 (Pubitemid 9129076)
16. Linzer, D. I., and Levine, A. J. (1979) Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43-52 (Pubitemid 9188209)
17. Reich, N. C., Oren, M., and Levine, A. J. (1983) Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol. 3, 2143-2150
18. Chu, F., Nusinow, D. A., Chalkley, R. J., Plath, K., Panning, B., and Burlingame, A. L. (2006) Mapping post-translational modifications of the histone variant MacroH2A1 using tandem mass spectrometry. Mol. Cell. Proteomics 5, 194-203
19. Chalkley, R. J., Baker, P. R., Huang, L., Hansen, K. C., Allen, N. P., Rexach, M., and Burlingame, A. L. (2005) Comprehensive analysis of a multidimensional liquid chromatography mass spectrometry dataset acquired on a quadrupole selecting, quadrupole collision cell, time-of-flight mass spectrometer: II. New developments in Protein Prospector allow for reliable and comprehensive automatic analysis of large datasets. Mol. Cell. Proteomics 4, 1194-1204
20. Tack, L. C., and Wright, J. H. (1992) Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection. J. Virol. 66, 1312-1320
21. Blaydes, J. P., Luciani, M. G., Pospisilova, S., Ball, H. M., Vojtesek, B., and Hupp, T. R. (2001) Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J. Biol. Chem. 276, 4699-4708
22. Lavin, M. F., and Gueven, N. (2006) The complexity of p53 stabilization and activation. Cell Death Differ. 13, 941-950
23. Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., Rassidakis, A., Halazonetis, T. D., Field, J. K., and Kittas, C. (1998) Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am. J. Pathol. 153, 1749-1765
24. Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., and Maeda, S. (1994) p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res. 54, 231-235 (Pubitemid 2019252)
25. Borger, D. R., and DeCaprio, J. A. (2006) Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. J. Virol. 80, 4292-4303
26. Saito, S., Yamaguchi, H., Higashimoto, Y., Chao, C., Xu, Y., Fomace, A. J., Jr., Appella, E., and Anderson, C. W. (2003) Phosphorylation site inter-dependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278, 37536-37544
27. Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D. (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19, 175-178
28. Sakaguchi, K., Sakamoto, H., Xie, D., Erickson, J. W., Lewis, M. S., Anderson, C. W., and Appella, E. (1997) Effect of phosphorylation on tetramerization of the tumor suppressor protein p53. J. Protein Chem. 16, 553-556
29. Lilyestrom, W., Klein, M. G., Zhang, R., Joachimiak, A., and Chen, X. S. (2006) Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20, 2373-2382 (Pubitemid 44320386)
30. Brown, D. R., Deb, S., Munoz, R. M., Subler, M. A., and Deb, S. P. (1993) The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein. Mol. Cell. Biol. 13, 6849-6857
31. Henning, W., Rohaly, G., Kolzau, T., Knippschild, U., Maacke, H., and Deppert, W. (1997) MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J. Virol. 71, 7609-7618 (Pubitemid 27391703)
32. Kishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., and Yamaizumi, M. (2001) Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J. Biol. Chem. 276, 39115-39122
33. Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., and McMahon, S. B. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24, 841-851 (Pubitemid 44960096)
34. Mellert, H., Sykes, S. M., Murphy, M. E., and McMahon, S. B. (2007) The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle 6, 1304-1306 (Pubitemid 47327961)
35. Nag, A., Germaniuk-Kurowska, A., Dimri, M., Sassack, M. A., Gurumurthy, C. B., Gao, Q., Dimri, G., Band, H., and Band, V. (2007) An essential role of human Ada3 in p53 acetylation. J. Biol. Chem. 282, 8812-8820
36. Mantovani, F., Tocco, F., Girardini, J., Smith, P., Gasco, M., Lu, X., Crook, T., and Del Sal, G. (2007) The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat. Struct. Mol. Biol. 14, 912-920
37. Prives, C., and Manley, J. L. (2001) Why is p53 acetylated? Cell 107, 815-818
38. Knights, C. D., Catania, J., Di Giovanni, S., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., and Avantaggiati, M. L. (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J. Cell Biol. 173, 533-544
39. Ito, A., Lai, C. H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., and Yao, T. P. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20, 1331-1340 (Pubitemid 32233973)
40. Rodriguez, M. S., Desterro, J. M., Lain, S., Lane, D. P., and Hay, R. T. (2000) Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome- mediated degradation. Mol. Cell. Biol. 20, 8458-8467